March 22, 2022 NOT FOR DISTRIBUTION IN THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, SOUTH AFRICA OR JAPANBayer refinances 1.3 billion euro hybrid bondRead more
March 22, 2022 Affini-T Therapeutics Completes $175 Million Financing Co-Led by Vida Ventures and Leaps by Bayer to Advance Groundbreaking T Cell Therapies for Solid Tumor Patients with Oncogenic Driver MutationsRead more
March 16, 2022 Prestigious award from the Bayer Foundation:2021 Hansen Family Award goes to Professor Kai JohnssonRead more
SPECIALIZED PRESS March 16, 2022 Not intended for U.S. and UK MediaBayer submits application in the EU for an extension of the indication of finerenone to include early stages of chronic kidney disease associated with type 2 diabetesRead more
SPECIALIZED PRESS March 11, 2022 Not intended for U.S. and UK MediaBayer submits application for additional indication of Nubeqa™ (darolutamide) in JapanRead more
March 10, 2022 Bayer to sell its Environmental Science Professional business to Cinven for 2.6 billion U.S. dollarsRead more
SPECIALIZED PRESS March 9, 2022 Not intended for U.S. and UK MediaBayer submits applications in the U.S. and EU for additional indication of Nubeqa™ (darolutamide)Read more
.jpg)
.jpg)
.jpg)
